More problems at Patheon's Puerto Rican production facilities in
the third quarter of 2006 are expected to reduce the contract
manufacturer's earnings before interest, tax, depreciation and
amortisation (EBITDA) by more...
Canadian contract manufacturer Patheon saw pre-tax profits remain
idle in the second quarter of 2006, leaving it struggling to find
ways to boost profitability.
Pfizer has sold a large manufacturing plant in Puerto Rico to
biopharmaceutical firm Abraxis for $32.5m (€25.4m), as it continues
to consolidate its manufacturing operations.
Canadian drug outsourcing company Patheon has reported its first
quarterly loss since its inception in 1974, swinging from a net
profit of $6m (€4.9m) in Q1 of 2005 to a net loss of $11.5m in Q1
of 2006, as problems with production...
Responding to growing demand, Biotechnology giant Amgen has
announced an expansion of its manufacturing facilities in Puerto
Rico, investing $1 billion (€835 million) in the project over the
next four years.
Pharmaceutical manufacturer Patheon has reaffirmed its dominant
position in the outsourcing market with the announcement of a
five-year master supply agreement with drug giant Merck.
Packaging company Alcan has said it plans to close its Cayey
pharmaceutical glass vial operation, based in Puerto Rico, in order
to streamline its North American vial manufacturing network.
Laboratory equipment supplier VWR International - recently sold by
Germany's Merck KGaA - has expanded in Ireland and Puerto Rico,
both hotbeds of the pharmaceutical manufacturing sector, via the
acquisition of local companies,...
US drug delivery company Inyx has signed a definitive agreement to
acquire Aventis Pharmaceuticals Puerto Rico, part of the French
Sanofi-Aventis group.
Ireland's position as a hot-spot for inwards investment in
pharmaceutical manufacturing is under threat from companies in the
Far East and Puerto Rico, according to PharmaChemical Ireland.
